Sukhatme Mayukh, President and CIO of Roivant Sciences Ltd. ($ROIV), sold about $38.5 million in company shares across four open market transactions over the last year. His most recent sale occurred on February 9, 2026. These sales rank 394th among 11,678 insiders in our database by total value sold, above the average of $8.6 million per insider and 6.4 transactions. Sukhatme Mayukh made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Common Shares | 58391 | $0.00 | 18,894,938.0000 | 696,859,682 | 0.31% | 0.01% |
| March 30, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Capped Value Appreciation Rights | 1306889 | $11.50 | 0.0000 | 696,859,682 | 100.00% | 0.19% |
| March 31, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | F | Common Shares | 187512 | $27.70 | 18,677,617.0000 | 696,859,682 | 0.99% | 0.03% |
| March 30, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | F | Common Shares | 29809 | $26.41 | 18,865,129.0000 | 696,859,682 | 0.16% | 0.00% |
| Feb. 9, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | S | Common Shares | 339441 | $26.47 | 19,148,664.0000 | 696,859,682 | 1.74% | 0.05% |
| Feb. 9, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Stock Option (Right to Buy) | 651558 | $0.00 | 0.0000 | 696,859,682 | 100.00% | 0.09% |
| Feb. 9, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | J | Common Shares | 312117 | $26.47 | 18,836,547.0000 | 696,859,682 | 1.63% | 0.04% |
| Feb. 9, 2026 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Common Shares | 651558 | $12.68 | 19,488,105.0000 | 696,859,682 | 3.46% | 0.09% |
| Dec. 29, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | S | Common Shares | 311873 | $21.74 | 19,273,032.0000 | 680,947,866 | 1.59% | 0.05% |
| Dec. 31, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Stock Option (Right to Buy) | 2449877 | $0.00 | 95,718.0000 | 680,947,866 | 96.24% | 0.36% |
| Dec. 29, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Stock Option (Right to Buy) | 748358 | $0.00 | 555,840.0000 | 680,947,866 | 57.38% | 0.11% |
| Dec. 31, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | J | Common Shares | 1430882 | $21.71 | 18,836,547.0000 | 680,947,866 | 7.06% | 0.21% |
| Dec. 31, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | S | Common Shares | 1018995 | $21.71 | 20,267,429.0000 | 680,947,866 | 4.79% | 0.15% |
| Dec. 31, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Common Shares | 2449877 | $12.68 | 21,286,424.0000 | 680,947,866 | 13.01% | 0.36% |
| Dec. 29, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | J | Common Shares | 436485 | $21.74 | 18,836,547.0000 | 680,947,866 | 2.26% | 0.06% |
| Dec. 29, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Common Shares | 748358 | $12.68 | 19,584,905.0000 | 680,947,866 | 3.97% | 0.11% |
| Dec. 17, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | S | Common Shares | 26831 | $23.09 | 18,869,229.0000 | 680,947,866 | 0.14% | 0.00% |
| Dec. 17, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Common Shares | 59513 | $12.68 | 18,896,060.0000 | 680,947,866 | 0.32% | 0.01% |
| Dec. 17, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | J | Common Shares | 32682 | $23.09 | 18,836,547.0000 | 680,947,866 | 0.17% | 0.00% |
| Dec. 17, 2025 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | President & CIO | M | Common Shares | 59513 | $0.00 | 1,304,198.0000 | 680,947,866 | 4.36% | 0.01% |
| Dec. 24, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Common Shares | 185946 | $3.85 | 19,022,493.0000 | 735,642,721 | 0.99% | 0.03% |
| Dec. 23, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | S | Common Shares | 10796 | $12.00 | 18,836,547.0000 | 735,642,721 | 0.06% | 0.00% |
| Dec. 26, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Stock Option (Right to Buy) | 689495 | $0.00 | 15,224,363.0000 | 735,642,721 | 4.33% | 0.09% |
| Dec. 24, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Stock Option (Right to Buy) | 185946 | $0.00 | 15,913,858.0000 | 735,642,721 | 1.15% | 0.03% |
| Dec. 23, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Stock Option (Right to Buy) | 10796 | $0.00 | 16,099,804.0000 | 735,642,721 | 0.07% | 0.00% |
| Dec. 26, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | S | Common Shares | 689495 | $12.01 | 18,836,547.0000 | 735,642,721 | 3.53% | 0.09% |
| Dec. 26, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Common Shares | 689495 | $3.85 | 19,526,042.0000 | 735,642,721 | 3.66% | 0.09% |
| Dec. 24, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | S | Common Shares | 185946 | $12.00 | 18,836,547.0000 | 735,642,721 | 0.98% | 0.03% |
| Dec. 23, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Common Shares | 10796 | $3.85 | 18,847,343.0000 | 735,642,721 | 0.06% | 0.00% |
| Dec. 18, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Common Shares | 412584 | $3.85 | 19,249,131.0000 | 735,642,721 | 2.19% | 0.06% |
| Dec. 18, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Stock Option (Right to Buy) | 412584 | $0.00 | 16,110,600.0000 | 735,642,721 | 2.50% | 0.06% |
| Dec. 18, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | S | Common Shares | 412584 | $12.05 | 18,836,547.0000 | 735,642,721 | 2.14% | 0.06% |
| Dec. 3, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | J | Common Shares | 3651985 | $12.21 | 18,836,547.0000 | 735,642,721 | 16.24% | 0.50% |
| July 26, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | A | Common Shares | 17000000 | $0.00 | 24,146,230.0000 | 831,049,444 | 237.89% | 2.05% |
| July 26, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | A | Common Shares | 1836547 | $0.00 | 7,146,230.0000 | 831,049,444 | 34.59% | 0.22% |
| March 30, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Common Shares | 729081 | $0.00 | 5,675,894.0000 | 712,791,115 | 14.74% | 0.10% |
| March 30, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | M | Capped Value Appreciation Rights | 1856163 | $6.40 | 0.0000 | 712,791,115 | 100.00% | 0.26% |
| March 30, 2024 | Roivant Sciences Ltd. | $ROIV | Sukhatme Mayukh | Pres&Chief Investment Officer | F | Common Shares | 366211 | $10.54 | 5,309,683.0000 | 712,791,115 | 6.45% | 0.05% |